Old Web
English
Sign In
Acemap
>
authorDetail
>
Walter P. Carney
Walter P. Carney
Mayo Clinic
Trastuzumab
Chemotherapy
Medicine
Breast cancer
HER2 Positive Breast Cancer
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab
2013
Cancer
Alvaro Moreno Aspitia
David W. Hillman
Stephen H. Dyar
Kathleen S. Tenner
Julie R. Gralow
Peter A. Kaufman
Nancy E. Davidson
Jacqueline M. Lafky
Monica M. Reinholz
Wilma L. Lingle
Leila Kutteh
Walter P. Carney
Amylou C. Dueck
Edith A. Perez
Show All
Source
Cite
Save
Citations (0)
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831
2013
Cancer
Alvaro Moreno Aspitia
David W. Hillman
Stephen H. Dyar
Kathleen S. Tenner
Julie R. Gralow
Peter A. Kaufman
Nancy E. Davidson
Jacqueline M. Lafky
Monica M. Reinholz
Wilma L. Lingle
Leila Kutteh
Walter P. Carney
Amylou C. Dueck
Edith A. Perez
Show All
Source
Cite
Save
Citations (34)
Soluble HER2 (sHER2) levels in HER2-positive breast cancer patients receiving chemotherapy ± trastuzumab: Results from the NCCTG adjuvant trial N9831
2013
Cancer
Alvaro Moreno Aspitia
David W. Hillman
Stephen H. Dyar
Kathleen S. Tenner
Julie R. Gralow
Peter A. Kaufman
Nancy E. Davidson
Jacqueline M. Lafky
Monica M. Reinholz
Wilma L. Lingle
Leila Kutteh
Walter P. Carney
Amylou C. Dueck
Edith A. Perez
Show All
Source
Cite
Save
Citations (1)
1